Platelets Function and Cardiovascular Events in Patients With End Stage Renal Disease
Recruitment status was: Recruiting
The purpose of this study is to perform a prospective evaluation regarding the relationship between platelets function and cardiovascular events in patients with ESRD.
The study will include 100-200 patients with ESRD, age 18 years or older, treated in the nephrology division of Assaf Harofeh medical center.
The primary end points of the study are cardiovascular events including acute myocardial infarction (defined as symptoms + acute elevation of TnI), need for coronary artery disease revascularization, or acute cerebrovascular event (TIA or CVA) and mortality. The secondary end points are any hospitalization due to acute coronary syndrome, active bleeding with the need for blood transfusion and dialysis access graft thrombosis (time to thrombosis).
Blood will be taken for complete blood count including platelets count and mean platelets volume, serum electrolytes, albumin, blood lipids, Kt/V, troponin and two 5 ml aliquots from each blood collection will be separated and stored at -70co until analyzed for oxidative stress, homocysteine and highly sensitive CRP will be performed. Five mL of blood will be sent for platelets function assessment.
During the follow up period the correlation between platelets function an cardiovascular events will be assessed.
|Study Design:||Observational Model: Defined Population
Time Perspective: Longitudinal
Time Perspective: Prospective
|Study Start Date:||September 2006|
|Estimated Study Completion Date:||December 2007|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00407368
|Nephrology Division, Aassaf-Harofeh Medical Center|
|Zerifin, Israel, 70300|
|Study Chair:||Shai Efrati, MD||Assaf-Harofeh Medical Center|
|Principal Investigator:||Mark Katz, MD||Assaf-Harofeh Medical Center|